2020.12.07.

AestheFill received ANVISA sanitary registration approval in Brazil

On December 7th 2020 AestheFill® was approved by the Brazilian Health Regulatory Agency (ANVISA) as a Class IV Medical Device. Brazil represents a large market for the product with 10,610,748 nonsurgical (injectable) procedures in 2020 according to the International Society of Aesthetic Plastic Surgery’s Global Survey Results.